Endoscopic Ultrasound Elastography in Pancreatic Masses
EUS-EG
Computer-aided Diagnosis of Endoscopic Ultrasound Elastography Used in the Differentiation of Focal Pancreatic Masses
2 other identifiers
observational
285
10 countries
18
Brief Summary
The aim of the study is to assess elastography during EUS examinations of focal pancreatic masses, and to consequently differentiate benign versus malignant pancreatic masses in a prospective multi-center design.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jun 2008
18 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 1, 2008
CompletedFirst Submitted
Initial submission to the registry
May 25, 2009
CompletedFirst Posted
Study publicly available on registry
May 27, 2009
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2009
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2009
CompletedJanuary 12, 2010
January 1, 2010
1.4 years
May 25, 2009
January 11, 2010
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Value of endoscopic ultrasound elastography for the differential diagnoses of pancreatic masses.
18 months
Study Arms (2)
Pancreatic adenocarcinoma
Patients diagnosed with solid pancreatic adenocarcinoma masses, with cytological / histological confirmation
Chronic pancreatitis
Patients diagnosed with solid pancreatic tumor masses with all the criteria fulfilled to exclude pancreatic cancer
Eligibility Criteria
The diagnosis of chronic pancreatitis will be based on the clinical information (history of alcohol abuse, previous diagnosis of chronic pancreatitis or diabetes mellitus), as well as a combination of imaging methods (ultrasound, CT and EUS). At least four criteria of chronic pancreatitis during EUS will be considered for the positive diagnosis. A positive cytological diagnosis will be taken as a final proof of malignancy of the pancreas mass. The diagnoses obtained by EUS-FNA will be further verified either by surgery or during a clinical follow-up of at least 6 months.
You may qualify if:
- Patients diagnosed with solid pancreatic tumor masses, with cytological / histological confirmation
- Age 18 to 80 years old, men or women
- Signed informed consent for EUS with elastography and FNA biopsy
You may not qualify if:
- Prior surgical treatment with curative intent or chemo-radiotherapy
- Patients diagnosed with mucin producing tumors, pancreatic cystic tumors, etc.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Medicine and Pharmacy Craiovalead
- University Hospital, Gentofte, Copenhagencollaborator
- Odense University Hospitalcollaborator
- Institut Paoli-Calmettescollaborator
- San Raffaele University Hospital, Italycollaborator
- UCL (Univ), Brussels, Belgiumcollaborator
- Glasgow Royal Infirmarycollaborator
- Caritas-Krankenhaus Bad Mergentheimcollaborator
- University of Bergencollaborator
- University of Witten/Herdeckecollaborator
- Newcastle-upon-Tyne Hospitals NHS Trustcollaborator
Study Sites (18)
Erasme University
Brussels, Belgium
Universite Chatolique Louvain
Brussels, Belgium
Gentofte University Hospital
Copenhagen, Denmark
University Hospital
Odense, Denmark
Institute Paoli Calmettes
Marseille, France
Caritas-Krankenhaus
Bad Mergentheim, Germany
St. Josef Hospital
Bochum, Germany
SRH Klinik
Gera, Germany
University Clinic Mainz
Mainz, Germany
Dr.Horst-Schmidt-Klinik
Wiesbaden, Germany
HELIOS Klinikum Wuppertal, University of Witten/Herdecke
Wuppertal, Germany
Hospital San Raffaele
Milan, Italy
Erasme Medisch Centrum
Rotterdam, Netherlands
University of Haukeland
Bergen, Norway
University of Medicine and Pharmacy Craiova
Craiova, Romania
University Hospital Santiago
Santiago, Spain
Glasgow Royal Infirmary
Glasgow, United Kingdom
Newcastle Upon Tyne Hospitals
Newcastle, United Kingdom
Related Publications (9)
Frey H. [Realtime elastography. A new ultrasound procedure for the reconstruction of tissue elasticity]. Radiologe. 2003 Oct;43(10):850-5. doi: 10.1007/s00117-003-0943-2. German.
PMID: 14605701BACKGROUNDOphir J, Alam SK, Garra B, Kallel F, Konofagou E, Krouskop T, Varghese T. Elastography: ultrasonic estimation and imaging of the elastic properties of tissues. Proc Inst Mech Eng H. 1999;213(3):203-33. doi: 10.1243/0954411991534933.
PMID: 10420776BACKGROUNDItoh A, Ueno E, Tohno E, Kamma H, Takahashi H, Shiina T, Yamakawa M, Matsumura T. Breast disease: clinical application of US elastography for diagnosis. Radiology. 2006 May;239(2):341-50. doi: 10.1148/radiol.2391041676. Epub 2006 Feb 16.
PMID: 16484352BACKGROUNDMiyanaga N, Akaza H, Yamakawa M, Oikawa T, Sekido N, Hinotsu S, Kawai K, Shimazui T, Shiina T. Tissue elasticity imaging for diagnosis of prostate cancer: a preliminary report. Int J Urol. 2006 Dec;13(12):1514-8. doi: 10.1111/j.1442-2042.2006.01612.x.
PMID: 17118027BACKGROUNDRago T, Santini F, Scutari M, Pinchera A, Vitti P. Elastography: new developments in ultrasound for predicting malignancy in thyroid nodules. J Clin Endocrinol Metab. 2007 Aug;92(8):2917-22. doi: 10.1210/jc.2007-0641. Epub 2007 May 29.
PMID: 17535993BACKGROUNDJanssen J, Schlorer E, Greiner L. EUS elastography of the pancreas: feasibility and pattern description of the normal pancreas, chronic pancreatitis, and focal pancreatic lesions. Gastrointest Endosc. 2007 Jun;65(7):971-8. doi: 10.1016/j.gie.2006.12.057.
PMID: 17531630BACKGROUNDSaftoiu A, Vilmann P, Ciurea T, Popescu GL, Iordache A, Hassan H, Gorunescu F, Iordache S. Dynamic analysis of EUS used for the differentiation of benign and malignant lymph nodes. Gastrointest Endosc. 2007 Aug;66(2):291-300. doi: 10.1016/j.gie.2006.12.039.
PMID: 17643702BACKGROUNDSaftoiu A, Vilmann P, Gorunescu F, Janssen J, Hocke M, Larsen M, Iglesias-Garcia J, Arcidiacono P, Will U, Giovannini M, Dietrich CF, Havre R, Gheorghe C, McKay C, Gheonea DI, Ciurea T; European EUS Elastography Multicentric Study Group. Efficacy of an artificial neural network-based approach to endoscopic ultrasound elastography in diagnosis of focal pancreatic masses. Clin Gastroenterol Hepatol. 2012 Jan;10(1):84-90.e1. doi: 10.1016/j.cgh.2011.09.014. Epub 2011 Oct 1.
PMID: 21963957DERIVEDSaftoiu A, Vilmann P, Gorunescu F, Janssen J, Hocke M, Larsen M, Iglesias-Garcia J, Arcidiacono P, Will U, Giovannini M, Dietrich C, Havre R, Gheorghe C, McKay C, Gheonea DI, Ciurea T; European EUS Elastography Multicentric Study Group. Accuracy of endoscopic ultrasound elastography used for differential diagnosis of focal pancreatic masses: a multicenter study. Endoscopy. 2011 Jul;43(7):596-603. doi: 10.1055/s-0030-1256314. Epub 2011 Mar 24.
PMID: 21437851DERIVED
Related Links
Biospecimen
Pathology samples obtained from duodeno-pancreatectomies or caudal pancreatectomies done with curative intent, as well as microhistological fragments obtained through EUS-FNA biopsy processed by paraffin embedding
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Adrian Saftoiu, Professor
University of Medicine and Pharmacy Craiova, Romania
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
May 25, 2009
First Posted
May 27, 2009
Study Start
June 1, 2008
Primary Completion
November 1, 2009
Study Completion
December 1, 2009
Last Updated
January 12, 2010
Record last verified: 2010-01